COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines

Author:

Taxonera Carlos,López-García Olga Neva

Publisher

Elsevier

Reference84 articles.

1. The impact of Vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry;Agrawal;Journal of Crohn's & Colitis,2021

2. Review article: Prevention, diagnosis and management of COVID-19 in the IBD patient. In;Al-Ani;Alimentary Pharmacology and Therapeutics,2020

3. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): A multicentre, prospective, case-control study;Alexander;The Lancet Gastroenterology and Hepatology,2022

4. Infección por SARS-CoV-2 en pacientes con enfermedad inflamatoria intestinal en la segunda y tercera ola y su comparación con los datos de la primera ola;Algaba;Gastroenterología y Hepatología,2021

5. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis;Allotey;The BMJ,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3